Literature DB >> 26573072

Metastatic Rhabdomyosarcoma: Still Room for Improvement.

Leonard H Wexler1.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26573072     DOI: 10.1200/JCO.2015.64.3395

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

1.  Matrine inhibits cell proliferation and induces apoptosis of human rhabdomyosarcoma cells via downregulation of the extracellular signal-regulated kinase pathway.

Authors:  Penghui Yan; Zongqiang Huang; Junbo Zhu
Journal:  Oncol Lett       Date:  2017-07-08       Impact factor: 2.967

2.  Isolated Breast Relapse after Metastatic Alveolar Rhabdomyosarcoma in a Young Premenarcheal Girl: What Could Have Been Done?

Authors:  Raymond N Haddad; Souad Ghattas; Paul-Henri Torbey
Journal:  Case Rep Oncol       Date:  2019-11-27

3.  The anti-tumor growth effect of a novel agent DMAMCL in rhabdomyosarcoma in vitro and in vivo.

Authors:  Ning Xu; Zhongyan Hua; Gen Ba; Simeng Zhang; Zhihui Liu; Carol J Thiele; Zhijie Li
Journal:  J Exp Clin Cancer Res       Date:  2019-03-08

Review 4.  Current and Future Treatment Strategies for Rhabdomyosarcoma.

Authors:  Celine Chen; Heathcliff Dorado Garcia; Monika Scheer; Anton G Henssen
Journal:  Front Oncol       Date:  2019-12-20       Impact factor: 6.244

5.  Embryonal Rhabdomyosarcoma Presenting as Lung Metastasis in an Adult: An Uncommon Presentation.

Authors:  Rabia Taseer; Tabeer T Ahmed
Journal:  Cureus       Date:  2021-02-24

6.  Is there a role for salvage re-irradiation in pediatric patients with locoregional recurrent rhabdomyosarcoma? Clinical outcomes from a multi-institutional cohort.

Authors:  Daniel V Wakefield; Bree R Eaton; Austin P H Dove; Chih-Yang Hsu; Thomas E Merchant; Alberto Pappo; Andrew M Davidoff; Natia Esiashvili; Matthew J Krasin; John T Lucas
Journal:  Radiother Oncol       Date:  2018-07-14       Impact factor: 6.280

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.